Your session is about to expire
← Back to Search
Behavioral Intervention
Virtual Reality for Stress and High Blood Pressure
N/A
Waitlist Available
Led By Judite Blanc, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Self-identified as a Black woman
At least 21 years of age
Must not have
Absence of vision and cognitive impairment
Absence of epilepsy disorders
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and up to 6 months
Awards & highlights
Summary
This trial aims to investigate whether a special virtual reality program can assist Black women in managing stress and enhancing heart health. The study will evaluate how VR impacts stress, sleep, and overall effectiveness in this group
Who is the study for?
This trial is for Black women who are experiencing high blood pressure and stress. Participants should be interested in using virtual reality (VR) as a tool to manage stress. The study will focus on the impact of VR on heart health, sleep quality, and overall stress levels.
What is being tested?
The Realist Women Study is testing whether a VR program can reduce stress and improve heart health among Black women. It compares the effects of standard educational materials (control group) with an immersive VR experience designed for stress management.
What are the potential side effects?
While not explicitly mentioned, potential side effects may include discomfort or dizziness from using VR equipment, eye strain, or possible emotional reactions to the content used within the VR program.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I identify as a Black woman.
Select...
I am at least 21 years old.
Select...
I have been diagnosed with high blood pressure.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My vision and thinking abilities are normal.
Select...
I do not have epilepsy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and up to 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Traumatic stress as measured by Life Events Checklist
Change in discrimination as measured by Intersectional Discrimination Index (InDI)
Change in stress as measured by Perceived Stress Scale (PSS)
+3 moreSecondary study objectives
Change in blood pressure
Change in objective sleep health as measured by Sleep Health Objective
Change in resiliency as measured by Connor-Davidson Resilience Scale (CD-RISC)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: VR-Stress Management GroupExperimental Treatment1 Intervention
Participants in this group will receive VR intervention for up to 6 months
Group II: Education Control GroupActive Control1 Intervention
Participants in this group will be exposed to standard care through educational materials for up to 6 months.
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
935 Previous Clinical Trials
422,157 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,889 Previous Clinical Trials
47,834,147 Total Patients Enrolled
Judite Blanc, PhDPrincipal InvestigatorUniversity of Miami
Share this study with friends
Copy Link
Messenger